SCHEMBL8375858

SCHEMBL8375858

CN(C)C(=O)Oc1cnccc1N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.46
GAA P10253 2/20 0.46
ALDH1A1 P00352 2/20 0.46
GLA P06280 1/20 0.46
NCEH1 Q6PIU2 5/20 0.45
RAB9A P51151 2/20 0.44
LMNA P02545 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
PKM P14618 1/20 0.40
NPC1 O15118 1/20 0.40
TSHR P16473 1/20 0.40
MEN1 O00255 1/20 0.40
KDM6B O15054 1/20 0.40
KDM4A O75164 1/20 0.40
MAPT P10636 1/20 0.40
THRB P10828 1/20 0.40
KMT2A Q03164 1/20 0.40
KDM4D Q6B0I6 1/20 0.40
KDM4C Q9H3R0 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL8375150 0.90 KDM4E (0.39) KDM4EGAAALDH1A1GLANCEH1
SCHEMBL8375135 0.83 MEN1 (0.49) KDM4EGAAALDH1A1GLARAB9A
SCHEMBL4634558 0.81 KDM4E (0.51) KDM4EGAAALDH1A1GLASMN1; SMN2
SCHEMBL4633602 0.79 ALDH1A1 (0.48) KDM4EGAAALDH1A1GLAMEN1
SCHEMBL28281678 0.78 KDM4E (0.44) KDM4EGAAALDH1A1GLAMEN1
SCHEMBL28007495 0.75 NCEH1 (0.58) ALDH1A1NCEH1RAB9ALMNASMN1; SMN2
SCHEMBL9017843 0.73 RAB9A (0.38) KDM4EGAAALDH1A1NCEH1RAB9A
SCHEMBL9017846 0.73 RAB9A (0.38) KDM4EGAAALDH1A1NCEH1RAB9A
SCHEMBL10731732 0.72 BCHE (0.50) KDM4EALDH1A1NCEH1RAB9ALMNA
SCHEMBL4634601 0.71 KDM4E (0.56) KDM4EGAAALDH1A1GLAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0477903-A2 Substituted-4-amino-3-pyridinols, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1992-04-01 EP claimed
US-5869480-A ALLEVIATING MEMORY DYSFUNCTION CHARACTERIZED BY CHOLINERGIC DEFICIT HOECHST MARION ROUSSEL INC. (US) 1999-02-09 US disclosed
US-5866565-A ALZHEIMER'S DISORDERS HOECHST MARION ROUSSEL INC. (US) 1999-02-02 US disclosed
US-5821239-A USEFUL FOR TREATING ALZHEIMER'S DISEASE CAUSED BY CHOLINERGIC DEFICIT FROMMER LAWRENCE & HUAG LLP (US) 1998-10-13 US disclosed
EP-0477903-A2 Substituted-4-amino-3-pyridinols, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1992-04-01 EP disclosed